First, although we observed IFNGR1 down-regulation in a widely used in vivo infection model and showed that IFNγ could drive this response in cultured mouse and human cells, it remains to be seen precisely how this regulatory mechanism impacts myeloid cell activation and host resistance in this or other infection models. The gene discussed is IFNGR1; the disease is infection.